Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

AbbVie settles Humira patent disputes with Sandoz

AbbVie Inc. settled all patent disputes with Novartis AG, granting the Swiss drugmaker a non-exclusive license to manufacture and sell a copycat version of the blockbuster drug Humira.

Read More »

Jury clears J&J of liability in NJ talc cancer case

A New Jersey jury cleared J&J of liability in a case involving a woman who alleged that the company’s talc-based products, including baby powder, contain asbestos and caused her cancer.

Read More »

Ionis and Roche agree on dry AMD treatment deal

Ionis Pharmaceuticals inked a deal worth more than $700 million with pharma giant Roche to develop an antisense drug for the treatment of complement-mediated diseases.

Read More »

Bristol-Myers to invest in Compugen, collaborate in clinical trials

Bristol-Myers Squibb and Israel’s Compugen will collaborate in clinical trials for patients with advanced solid tumors.

Read More »

Allogene Therapeutics Announces Pricing of Initial Public Offering

Allogene Therapeutics Inc., a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) therapies for cancer, announced the pricing of an initial public offering of 18,000,000 shares of common stock at a price to the public of $18.00 per share.

Read More »

CVS, Aetna win U.S. approval for merger

Pharmacy chain CVS Health Corp. won U.S. antitrust approval for the $69 billion acquisition of health insurer Aetna Inc., the Justice Department said.

Read More »

Gotham Therapeutics Launches in New York City with $54 Million Series A Financing

Gotham Therapeutics launched in New York with a $54 million Series A financing. The round was co-led by founding investor Versant Ventures, Forbion, and S.R. One.

Read More »

Merck’s Frazier Joins Growing List of Pharma CEOs Attacking Drug Rebates

Merck & Co. CEO Kenneth Frazier, speaking with the Economic Club of New York, joined a growing list of pharmaceutical chiefs in criticizing the role of middlemen in rising drug prices.

Read More »

Novartis to Launch Innovation Labs Across the Globe, Including Silicon Valley

To spur innovation and bolster ties with tech giants, Swiss pharma giant Novartis plans to set up innovation labs across the globe to partner with these companies to spur the development of new therapies.

Read More »

Seattle Genetics’ Adcetris Has Potential to Change Treatment for T-Cell Lymphoma

Seattle Genetics and development partner Takeda Pharmaceutical announced stellar Phase III data from the ECHELON-2 clinical trial of Adcetris (brentuximab vedotin) for peripheral T-cell lymphoma.

Read More »

GSK Funds New Startup with Immunometabolic Focus

Backed by GlaxoSmithKline and Boston’s SV Health Investors, a new biopharmaceutical company known as Sitryx launched with $30 million in a Series A funding round.

Read More »

Can AI Detect Parkinson’s Disease from a Video? Tencent and Medopad Team up to Find Out

Medopad, a U.K.-based medical firm, and China-based Tencent Holdings have teamed up on a project that will attempt to harness artificial intelligence in the diagnosis of Parkinson’s disease.

Read More »

Johnson & Johnson Vision Launches Worldwide Campaign to #SpotlightSight in Honor of World Sight Day

Johnson & Johnson Vision, a broad-based global leader in eye health, launched a worldwide campaign to #spotlightsight in honor of World Sight Day on October 11, 2018.

Read More »

Evotec and Sanofi Further Therapeutic Drug Discovery

Evotec announced that Sanofi will be participating in an organized Public Private Partnership to further the discovery of cutting-edge therapeutic drugs in multiple areas.

Read More »

BIO Calls for Increased Gender Diversity

After negative reports about after-hours parties that have been deemed disrespectful toward women and multiple reports about the lack of gender diversity on industry boards of directors, biotech’s largest trade association is taking action.

Read More »

Parkinson’s Patient Files Discrimination Lawsuit Against Biogen, Adding to Other Former Employee Suits

Aldrin Carao, a former employee in Biogen’s IT department, filed a lawsuit in federal court last month claiming the company discriminated against him because of his Parkinson’s disease.

Read More »

Bayer Cutting More Than 200 Jobs in San Francisco Bay Area

German company Bayer AG is laying off 227 staffers at the company’s manufacturing plant in Berkeley, California. Most of the cuts took place on October 3, 2018.

Read More »

J&J, Arrowhead reach gene-silencing drug deal

J&J agreed to develop and market Arrowhead Pharmaceuticals Inc.’s gene-silencing hepatitis B treatment and buy a minor stake in a deal that could be potentially worth more than $3.7 billion.

Read More »

Boston Pharma Doubles Pipeline with 2 Deals with Novartis and GSK

Boston Pharmaceuticals licenses a slew of compounds from GlaxoSmithKline and Novartis in two separate deals.

Read More »

With Hemlibra, Roche seeks to break into tight hemophilia circle

Swiss drugmaker Roche is breaking into hemophilia A treatment, a $10 billion global market dominated by rivals who have cultivated close ties to sufferers of the genetic bleeding disorder.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!

Subscribe

Ad Right Bottom